← GE HealthCare Technologies Inc.

Annual Trend FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total revenues $17.6b $18.3b $19.6b $19.7b $20.6b
Cost of sales $10.4b $11.2b $11.6b $11.5b $12.4b
Gross profit $7.2b $7.2b $7.9b $8.2b $8.2b
Research and development $816.0m $1.0b $1.2b $1.3b $1.3b
Selling, general, and administrative $3.6b $3.6b $4.3b $4.3b $4.2b
Total operating expenses $4.4b $4.7b $5.5b $5.6b $5.5b
Operating income $2.8b $2.5b $2.4b $2.6b $2.8b
Interest and other financial charges – net $40.0m $77.0m $542.0m $504.0m $440.0m
Income from continuing operations before income taxes $2.9b $2.5b $2.4b $2.6b $2.8b
Benefit (provision) for income taxes ($600.0m) ($563.0m) ($743.0m) ($531.0m) ($614.0m)
Net income from continuing operations $2.3b $1.9b $1.6b $2.0b $2.2b
Income (loss) from discontinued operations, net of taxes $18.0m $18.0m ($4.0m) $0 $0
Net (income) loss attributable to noncontrolling interests ($46.0m) ($51.0m) ($46.0m) ($57.0m) ($70.0m)
Deemed preferred stock dividend of redeemable noncontrolling interest $0 $0 ($183.0m) $0 $0
Net income $2.3b $2.0b $1.6b $2.0b $2.2b
Net income attributable to GE HealthCare $2.2b $1.9b $1.6b $2.0b $2.1b
Net income attributable to GE HealthCare common stockholders $2.2b $1.9b $1.4b $2.0b $2.1b
Basic (in dollars per share) $5.01 $4.29 $3.56 $4.50 $4.72
Diluted (in dollars per share) $5.01 $4.29 $3.53 $4.47 $4.70
Non-operating benefit (income) costs $3.0m ($5.0m) ($382.0m) ($406.0m) ($288.0m)
Other (income) expense – net ($123.0m) ($62.0m) ($86.0m) ($55.0m) ($157.0m)

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.